Literature DB >> 11597672

Bradykinin B2BKR receptor polymorphism and left-ventricular growth response.

D Brull, S Dhamrait, S Myerson, J Erdmann, D Woods, M World, D Pennell, S Humphries, V Regitz-Zagrosek, H Montgomery.   

Abstract

Angiotensin-converting-enzyme (ACE) activity regulates left-ventricular growth. The deletion (D), rather than the insertion (I), ACE gene variant is associated with increased ACE activity and kinin degradation, and the absence (-) rather than the presence (+) of a 9 bp deletion in the gene encoding the bradykinin 2 receptor (B2BKR) is associated with greater gene expression. We determined the ACE and B2BKR genotype of 109 male army recruits, and measured their physiological left-ventricular growth response to a 10-week physical training programme. Mean left-ventricular growth was 15.7 g (SE 3.5) in those with ACE genotype D/D and B2BKR genotype +9/+9, but -1.37 g (4.1) in those with ACE genotype I/I and B2BKR genotype -9/-9 (p=0.003 for trend across genotypes). These results suggest that kinins regulate left-ventricular growth, mediating some of the effects of ACE in this regard.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597672     DOI: 10.1016/s0140-6736(01)06273-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

2.  Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.

Authors:  David M Flavell; Peter T E Wootton; Saul G Myerson; Michael J World; Dudley J Pennell; Steve E Humphries; Philippa J Talmud; Hugh E Montgomery
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

Review 3.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

Review 4.  Cardiac target organ damage in hypertension: insights from epidemiology.

Authors:  Patrick R Lawler; Pranoti Hiremath; Susan Cheng
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  The pathophysiology of hereditary angioedema.

Authors:  Bruce L Zuraw
Journal:  World Allergy Organ J       Date:  2010-09       Impact factor: 4.084

6.  BDKRB2 +9/-9 bp polymorphisms influence BDKRB2 expression levels and NO production in knee osteoarthritis.

Authors:  Shuo Chen; Lei Zhang; Ruonan Xu; Yunfan Ti; Yunlong Zhao; Liwu Zhou; Jianning Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

7.  Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.

Authors:  Juan C Osorio; Faisal H Cheema; Timothy P Martens; Naila Mahmut; Caroline Kinnear; Ana M D Gonzalez; William Bonney; Shunichi Homma; James K Liao; Seema Mital
Journal:  Can J Physiol Pharmacol       Date:  2008-09       Impact factor: 2.273

8.  Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.

Authors:  Gary P Van Guilder; Mias Pretorius; James M Luther; J Brian Byrd; Kevin Hill; James V Gainer; Nancy J Brown
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

9.  A capillary electrophoresis method for genotyping the 9-bp exon 1 insertion/deletion in BDKRB2.

Authors:  Jasmine Talameh; Anne Misher; Janelle Hoskins
Journal:  Pharmacogenomics       Date:  2012-02       Impact factor: 2.533

10.  The effect of bradykinin B2 receptor polymorphisms on the susceptibility and severity of osteoarthritis in a Chinese cohort.

Authors:  Shuo Chen; Yong Zhou; Jun Li; Le-Qun Shan; Qing-Yu Fan
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.